Influenza Vaccine Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Antigen Vaccine, Dendric Cell Vaccine, DNA Vaccine, Others), By Applications (Preventive Vaccine, Therapeutic Vaccine) , and Regional Insights and Forecast to 2035

Detailed TOC of Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2026-2035

Table of Content

1 Influenza Vaccine Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Influenza Vaccine Market Size (2021-2035)
1.3.1 Global Influenza Vaccine Revenue ($) and Growth Rate (2021-2035)
1.3.2 Global Influenza Vaccine Sales Volume and Growth Rate (2021-2035)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global Influenza Vaccine Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Influenza Vaccine Historic Revenue ($) by Type (2021-2026)
2.2 Global Influenza Vaccine Historic Sales Volume by Type (2021-2026)
2.3 Antigen Vaccine Sales and Price (2021-2026)
2.4 Dendric Cell Vaccine Sales and Price (2021-2026)
2.5 DNA Vaccine Sales and Price (2021-2026)
2.6 Others Sales and Price (2021-2026)

3 Global Influenza Vaccine Historic Revenue ($) and Sales Volume by Application (2021-2026)
3.1 Global Influenza Vaccine Historic Revenue ($) by Application (2021-2026)
3.2 Global Influenza Vaccine Historic Sales Volume by Application (2021-2026)
3.3 Preventive Vaccine Sales, Revenue and Growth Rate (2021-2026)
3.4 Therapeutic Vaccine Sales, Revenue and Growth Rate (2021-2026)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Influenza Vaccine Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Influenza Vaccine Industry News
4.7.2 Influenza Vaccine Industry Policies

5 Global Influenza Vaccine Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Influenza Vaccine Sales Volume by Region (2021-2026)
5.2 Global Influenza Vaccine Market Revenue ($) by Region (2021-2026)

6 Global Influenza Vaccine Import Volume and Export Volume by Major Regions
6.1 Global Influenza Vaccine Import Volume by Region (2021-2026)
6.2 Global Influenza Vaccine Export Volume by Region (2021-2026)

7 North America Influenza Vaccine Market Current Status (2021-2026)
7.1 Overall Market Size Analysis (2021-2026)
7.1.1 North America Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
7.1.2 North America Influenza Vaccine Sales Volume and Growth Rate (2021-2026)
7.2 North America Influenza Vaccine Market Trends Analysis Under Global Inflation
7.3 North America Influenza Vaccine Sales Volume and Revenue ($) by Country (2021-2026)
7.4 United States
7.4.1 United States Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
7.5 Canada
7.5.1 Canada Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)

8 Asia Pacific Influenza Vaccine Market Current Status (2021-2026)
8.1 Overall Market Size Analysis (2021-2026)
8.1.1 Asia Pacific Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
8.1.2 Asia Pacific Influenza Vaccine Sales Volume and Growth Rate (2021-2026)
8.2 Asia Pacific Influenza Vaccine Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Influenza Vaccine Sales Volume and Revenue ($) by Country (2021-2026)
8.4 China
8.4.1 China Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
8.5 Japan
8.5.1 Japan Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
8.6 India
8.6.1 India Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
8.7 South Korea
8.7.1 South Korea Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
8.8 Southeast Asia
8.8.1 Southeast Asia Influenza Vaccine Revenue ($) by Country (2021-2026)
8.9 Australia
8.9.1 Australia Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)

9 Europe Influenza Vaccine Market Current Status (2021-2026)
9.1 Overall Market Size Analysis (2021-2026)
9.1.1 Europe Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
9.2.1 Europe Influenza Vaccine Sales Volume and Growth Rate (2021-2026)
9.2 Europe Influenza Vaccine Market Trends Analysis Under Global Inflation
9.3 Europe Influenza Vaccine Sales Volume and Revenue ($) by Country (2021-2026)
9.4 Germany
9.4.1 Germany Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
9.5 France
9.5.1 France Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
9.6 United Kingdom
9.6.1 United Kingdom Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
9.7 Italy
9.7.1 Italy Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
9.8 Spain
9.8.1 Spain Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
9.9 Russia
9.9.1 Russia Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
9.10 Poland
9.10.1 Poland Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)

10 Latin America Influenza Vaccine Market Current Status (2021-2026)
10.1 Overall Market Size Analysis (2021-2026)
10.1.1 Latin America Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
10.1.2 Latin America Influenza Vaccine Sales Volume and Growth Rate (2021-2026)
10.2 Latin America Influenza Vaccine Market Trends Analysis Under Global Inflation
10.3 Latin America Influenza Vaccine Sales Volume and Revenue ($) by Country (2021-2026)
10.4 Mexico
10.4.1 Mexico Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
10.5 Brazil
10.5.1 Brazil Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
10.6 Argentina
10.6.1 Argentina Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)

11 Middle East and Africa Influenza Vaccine Market Current Status (2021-2026)
11.1 Overall Market Size Analysis (2021-2026)
11.1.1 Middle East and Africa Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
11.2.1 Middle East and Africa Influenza Vaccine Sales Volume and Growth Rate (2021-2026)
11.2 Middle East and Africa Influenza Vaccine Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Influenza Vaccine Sales Volume and Revenue ($) by Country (2021-2026)
11.4 GCC Countries
11.4.1 GCC Countries Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)
11.5 Africa
11.5.1 Africa Influenza Vaccine Revenue ($) and Growth Rate (2021-2026)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Influenza Vaccine Revenue ($) and Market Share of Key Players
12.1.2 Global Influenza Vaccine Sales Volume and Market Share of Key Players
12.1.3 Global Influenza Vaccine Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 Shanghai Institute of Biological Products Co., Ltd. Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 Shanghai Institute of Biological Products Co., Ltd. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 FluGen Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 FluGen Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 GlaxoSmithKline (GSK) Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 GlaxoSmithKline (GSK) Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 Gamma Vaccines Pty Ltd. Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 Gamma Vaccines Pty Ltd. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 SIOBP Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 SIOBP Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 CHANGSHENG Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 CHANGSHENG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 ABBOTT Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 ABBOTT Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 Mylan Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 Mylan Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 Seqirus (CSL Limited) Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 Seqirus (CSL Limited) Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.11 HUALAN BIO Market Performance and Business Analysis
12.11.1 Company Profiles
12.11.2 Product Profiles and Application
12.11.3 HUALAN BIO Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.12 BiondVax Pharmaceuticals Ltd Market Performance and Business Analysis
12.12.1 Company Profiles
12.12.2 Product Profiles and Application
12.12.3 BiondVax Pharmaceuticals Ltd Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.13 Hualan Biological Engineering Inc. Market Performance and Business Analysis
12.13.1 Company Profiles
12.13.2 Product Profiles and Application
12.13.3 Hualan Biological Engineering Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.14 Sinovac Biotech Ltd. Market Performance and Business Analysis
12.14.1 Company Profiles
12.14.2 Product Profiles and Application
12.14.3 Sinovac Biotech Ltd. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.15 DaiichiSankyo Market Performance and Business Analysis
12.15.1 Company Profiles
12.15.2 Product Profiles and Application
12.15.3 DaiichiSankyo Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.16 Moderna Market Performance and Business Analysis
12.16.1 Company Profiles
12.16.2 Product Profiles and Application
12.16.3 Moderna Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.17 Sanofi Market Performance and Business Analysis
12.17.1 Company Profiles
12.17.2 Product Profiles and Application
12.17.3 Sanofi Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.18 BioDiem Market Performance and Business Analysis
12.18.1 Company Profiles
12.18.2 Product Profiles and Application
12.18.3 BioDiem Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.19 Altimmune Market Performance and Business Analysis
12.19.1 Company Profiles
12.19.2 Product Profiles and Application
12.19.3 Altimmune Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.20 AstraZeneca Market Performance and Business Analysis
12.20.1 Company Profiles
12.20.2 Product Profiles and Application
12.20.3 AstraZeneca Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.21 Mitsubishi Tanabe Pharma Market Performance and Business Analysis
12.21.1 Company Profiles
12.21.2 Product Profiles and Application
12.21.3 Mitsubishi Tanabe Pharma Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.22 Novavax Market Performance and Business Analysis
12.22.1 Company Profiles
12.22.2 Product Profiles and Application
12.22.3 Novavax Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the Influenza Vaccine Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Influenza Vaccine
13.3.3 Raw Material Cost of Influenza Vaccine
13.3.4 Labor Cost of Influenza Vaccine
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global Influenza Vaccine Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Influenza Vaccine Revenue ($) and Sales Volume Forecast by Type (2026-2035)
15.1.1 Global Influenza Vaccine Revenue ($) Forecast by Type (2026-2035)
15.1.2 Global Influenza Vaccine Sales Volume Forecast by Type (2026-2035)
15.2 Global Influenza Vaccine Revenue ($) and Sales Volume Forecast by Application (2026-2035)
15.2.1 Global Influenza Vaccine Revenue ($) Forecast by Application (2026-2035)
15.2.2 Global Influenza Vaccine Sales Volume Forecast by Application (2026-2035)
15.3 Global Influenza Vaccine Sales Volume Forecast by Region (2026-2035)
15.4 Global Influenza Vaccine Revenue ($) Forecast by Region (2026-2035)

16 Research Findings and Conclusion